Dr Kyle Lapidus is the Medical Director at Journey Clinical. After receiving his BA from Harvard University, Dr Lapidus earned his MD and PhD at Albert Einstein College of Medicine. Dr. Lapidus has particular clinical expertise in the management of treatment-resistant depression, obsessive-compulsive disorder (OCD), and attention-deficit disorder (ADD/ADHD). Additionally, he has worked on a number of studies involving the use of ketamine.
Explore more info with a membership (any level)
🧑 Extended profile information
📈 In-depth psychedelic reports (Sprout & Tree)
🪄 Weekly psychedelic research & implementation newsletter (free)